Ritholtz Wealth Management Raises Stock Position in Utah Medical Products, Inc. $UTMD

Ritholtz Wealth Management grew its stake in Utah Medical Products, Inc. (NASDAQ:UTMD) by 168.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,807 shares of the medical instruments supplier’s stock after purchasing an additional 9,293 shares during the quarter. Ritholtz Wealth Management owned about 0.47% of Utah Medical Products worth $918,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Invesco Ltd. increased its position in shares of Utah Medical Products by 4.2% during the fourth quarter. Invesco Ltd. now owns 6,020 shares of the medical instruments supplier’s stock valued at $337,000 after buying an additional 243 shares during the period. Mercer Global Advisors Inc. ADV lifted its holdings in Utah Medical Products by 6.5% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 7,805 shares of the medical instruments supplier’s stock worth $437,000 after buying an additional 478 shares during the period. Osaic Holdings Inc. lifted its holdings in Utah Medical Products by 8.9% in the fourth quarter. Osaic Holdings Inc. now owns 9,006 shares of the medical instruments supplier’s stock worth $504,000 after buying an additional 739 shares during the period. &PARTNERS boosted its position in Utah Medical Products by 11.6% during the 4th quarter. &PARTNERS now owns 3,796 shares of the medical instruments supplier’s stock valued at $212,000 after acquiring an additional 396 shares in the last quarter. Finally, Royal Bank of Canada boosted its position in Utah Medical Products by 8.8% during the 4th quarter. Royal Bank of Canada now owns 7,100 shares of the medical instruments supplier’s stock valued at $398,000 after acquiring an additional 575 shares in the last quarter. 69.60% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Utah Medical Products in a report on Friday, May 22nd. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Utah Medical Products Price Performance

Shares of Utah Medical Products stock opened at $73.97 on Monday. The stock has a market cap of $235.22 million, a price-to-earnings ratio of 21.88 and a beta of 0.37. The firm’s 50-day moving average is $66.56 and its 200 day moving average is $63.63. Utah Medical Products, Inc. has a 1 year low of $53.66 and a 1 year high of $75.75.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. The business had revenue of $8.72 million during the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.13%.

Utah Medical Products Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 3rd. Stockholders of record on Wednesday, June 17th will be issued a dividend of $0.31 per share. The ex-dividend date is Wednesday, June 17th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.7%. Utah Medical Products’s dividend payout ratio is presently 36.69%.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).